Gemtuzumab ozogamicin in acute myeloid leukemia: act 2, with perhaps more to come

Division of Hematology/Oncology, The Hospital for Sick Children and Developmental and Stem Cell Biology, The Hospital for Sick Children Research Institute, Toronto, ON, Canada
Division of Hematology University of Washington Medical Center and Clinical Research Division Fred Hutchinson Cancer Research Center Seattle, WA, USA
Vol. 104 No. 1 (2019): January, 2019 https://doi.org/10.3324/haematol.2018.205948